Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224895
Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Follicular lymphoma (FL) is the most frequent indolent lymphoma. Some patients (10%-15%) experience histologic transformation (HT) to a more aggressive lymphoma, usually diffuse large Bcell lymphoma (DLBCL). This study aimed to validate and improve a genetic risk model to predict HT at diagnosis.We collected mutational data from diagnosis biopsies of 64 FL patients. We combined them with the data from a previously published cohort (total n 1/4 104; 62 from nontransformed and 42 from patients who did transform to DLBCL). This combined cohort was used to develop a nomogram to estimate the risk of HT. Prognostic mutated genes and clinical variables were assessed using Cox regression analysis to generate a risk model. The model was internally validated by bootstrapping and externally validated in an independent cohort. Its performance was evaluated using a concordance index and a calibration curve. The clinicogenetic nomogram included the mutational status of 3 genes (HIST1HE1, KMT2D, and TNFSR14) and high-risk Follicular Lymphoma International Prognostic Index and predicted HT with a concordance index of 0.746. Patients were classified as being at low or high risk of transformation. The probability HT function at 24 months was 0.90 in the low-risk group vs 0.51 in the high-risk group and, at 60 months, 0.71 vs 0.15, respectively. In the external validation cohort, the probability HT function in the low-risk group was 0.86 vs 0.54 in the high-risk group at 24 months, and 0.71 vs 0.32 at 60 months. The concordance index in the external cohort was 0.552. In conclusion, we propose a clinicogenetic risk model to predict FL HT to DLBLC, combining genetic alterations in HIST1H1E, KMT2D, and TNFRSF14 genes and clinical features (Follicular Lymphoma International Prognostic Index) at diagnosis. This model could improve the management of FL patients and allow treatment strategies that would prevent or delay transformation. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
Matèries (anglès)
Citació
Citació
FERNÁNDEZ MIRANDA, Ismael, PEDROSA, Lucía, GONZÁLEZ RINCÓN, Julia, ESPINET, Blanca, LA CRUZ VICENTE, Fátima de, CLIMENT, Fina, GÓMEZ, Sagrario, ROYUELA, Ana, CAMACHO, Francisca i., MARTÍN ACOSTA, Paloma, YANGUAS CASÁS, Natalia, DOMÍNGUEZ, Marina, MENDEZ, Miriam, COLOMO, Luis, SALAR, Antonio, HORCAJO, Beatriz, NAVARRO, Marta, GARCÍA COSIO, Mónica, PIRIS VILLAESPESA, Miguel, LLANOS, Marta, GARCÍA, Juan f., SEQUERO, Silvia, MERCADAL, Santiago, GARCÍA HERNÁNDEZ, Sonia, NAVARRO, Belén, MOLLEJO, Manuela, PROVENCIO, Mariano, SÁNCHEZ BEATO, Margarita. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma. _Modern Pathology_. 2024. Vol. 37, núm. 7, pàgs. 100516. [consulta: 21 de desembre de 2025]. ISSN: 0893-3952. [Disponible a: https://hdl.handle.net/2445/224895]